Table 4 Four RCTs investigated the effect of PA on sleep in people with cancer
Authors (year) | Design | Participants | Country | Duration | Intervention and measures | Outcome measures (Sleep related) | Main findings (sleep-related) |
|---|---|---|---|---|---|---|---|
Roveda et al (2017) [48] | RP | 40 breast cancer women 55.2 (± 6.8) years for the intervention group and 58.2 (± 6.4) years for the control group | Italy | 3 months | 2 sessions of 1-h brisk walking per week for 3 months The heart rate monitor | Actigraph Actiwatch | Control group showed a generalized deterioration of their sleep behavior, whereas the intervention group maintained their sleep behavior more stable |
Rogers et al. (2017) [49] | RP | 222 post-primary treatment breast cancer survivors (mean age of 54.4 years) | USA | 3 months | physical activity behavior change intervention | PSQI and wrist-worn accelerometer | intervention group significantly improved PSQI global sleep quality when compared with usual care at 3 months( p < .001) and 6 months( P = .01) |
Rastogi et al. (2020) [60] | RP | 50 breast and colorectal cancer survivors 96% female aged 54.4 ± 11.2 years | USA | 12 weeks | 12-week multi-component physical activity module Gradually increase their MVPA to 150 min/week and daily steps to 10 000 Fitbit tracker ActiGraph GT3X +  | Patient Reported Outcomes Measurement Information System's (PROMIS) sleep measures, 8-item short forms | Greater reduction in both sleep disturbance and impairment among the cancer survivors in the intervention group from baseline to 12-weeks relative to the comparison group Both scales were associated with medium effect sizes, with impairment (d =  − 0.62) improving more than disturbance (d =  − 0.46) |
Nguyen et al. (2021) [50] | RP | 83 inactive, postmenopausal breast cancer survivors(aged 62 ± 6.4 years) | Australia | 12 weeks | a wearable-based physical activity intervention (Garmin Vivofit2® coupled with behavioral feedback, goal setting, and health coaching) | Wrist-worn actigraphy and PSQI | After intervention, primary intervention participants had greater improvements in WASO (− 5.7 min, 95% CI − 11.7 to − 0.2) and NWAKE compared with the waitlist arm (− 2.0, 95% CI − 3.6 to − 0.4) At 24 weeks later, within-group improvements were observed for SE (both groups), WASO (both groups), NWAKE (primary intervention group only), total PSQI score (primary intervention group), and sleep efficacy (primary intervention group) |